Resultado de búsqueda
30 de abr. de 2021 · Atypical small acinar proliferation is a histopathological diagnosis of unspecified importance in prostate needle-biopsy reports, suggestive but not definitive for cancer.
Atypical small acinar proliferation (ASAP) was found to differ significantly from minimal cancer in several respects. Among architectural findings, ASAP foci averaged 0.4mm, versus 0.8mm...
RESULTS: Incidence of atypical acini was 4%. A total of 46.7% of patients undergoing a repeat biopsy presented prostate cancer. We did not find significant differences in the clinical variables studied between patients with or without a definite cancer diagnosis.
Evaluar la incidencia de atipia acinar en nuestra serie, el porcentaje de cáncer de próstata y otras lesiones sospechosas o preneoplásicas en las biopsias sucesivas y establecer una estrategia de seguimiento en estos pacientes. Material y Método.
In urologic pathology, atypical small acinar proliferation, is a collection of small prostatic glands, on prostate biopsy, whose significance is uncertain and cannot be determined to be benign or malignant.
14 de sept. de 2015 · Atypical small acinar proliferation (ASAP) is diagnosed in 1-2% of prostate biopsies. 30–40% of patients with ASAP may be diagnosed with prostate cancer (PCa) on repeat biopsy. Our objective was to examine the association between ASAP and subsequent diagnosis of intermediate/high risk PCa.
30 de nov. de 2021 · Atypical small acinar proliferation (ASAP) occurs in approximately 5% of prostate biopsies. Approximately 30–40% of patients with ASAP have biopsy detectable prostate cancer (PCa) within 5 years....
